American Century Companies’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505K | Buy |
75,094
+7,301
| +11% | +$49.1K | ﹤0.01% | 2525 |
|
|
2025
Q1 | $613K | Buy |
67,793
+8,083
| +14% | +$73.1K | ﹤0.01% | 2430 |
|
|
2024
Q4 | $1.03M | Buy |
59,710
+8,985
| +18% | +$155K | ﹤0.01% | 2249 |
|
|
2024
Q3 | $811K | Sell |
50,725
-334,248
| -87% | -$5.34M | ﹤0.01% | 2314 |
|
|
2024
Q2 | $5.49M | Buy |
384,973
+18,625
| +5% | +$265K | ﹤0.01% | 1485 |
|
|
2024
Q1 | $5.19M | Buy |
366,348
+127,703
| +54% | +$1.81M | ﹤0.01% | 1439 |
|
|
2023
Q4 | $3.6M | Buy |
238,645
+99,847
| +72% | +$1.51M | ﹤0.01% | 1521 |
|
|
2023
Q3 | $2.19M | Buy |
138,798
+114,011
| +460% | +$1.8M | ﹤0.01% | 1662 |
|
|
2023
Q2 | $375K | Buy |
+24,787
| New | +$375K | ﹤0.01% | 2327 |
|